SCHEMBL21709893

SCHEMBL21709893

COc1ccc(C(=O)c2ccc(C)cc2)c(OC)c1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.84
LMNA P02545 4/20 0.71
KMT2A Q03164 3/20 0.71
MEN1 O00255 2/20 0.71
CYP1A2 P05177 2/20 0.71
CYP2C19 P33261 2/20 0.71
CYP3A4 P08684 1/20 0.71
TSHR P16473 1/20 0.71
HTT P42858 4/20 0.71
MAPT P10636 3/20 0.71
NPSR1 Q6W5P4 1/20 0.71
ALDH1A1 P00352 5/20 0.63
POLB P06746 2/20 0.61
KDM4E B2RXH2 1/20 0.61
SMN1; SMN2 Q16637 2/20 0.60
RAB9A P51151 3/20 0.58
AHR P35869 1/20 0.58
CYP2C9 P11712 1/20 0.55
RXFP1 Q9HBX9 1/20 0.55
GAA P10253 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29414999 0.92 NPC1 (1.00) NPC1LMNAKMT2AMEN1CYP1A2
SCHEMBL5902231 0.92 NPC1 (1.00) NPC1LMNAKMT2AMEN1CYP1A2
SCHEMBL18917635 0.89 NPC1 (0.68) NPC1LMNAKMT2AMEN1CYP1A2
SCHEMBL854757 0.87 NPC1 (0.84) NPC1LMNAKMT2AMEN1CYP1A2
SCHEMBL29394510 0.87 NPC1 (0.84) NPC1LMNAKMT2AMEN1CYP1A2
SCHEMBL1539237 0.87 HTT (0.65) NPC1LMNAKMT2AMEN1CYP1A2
SCHEMBL9545150 0.86 NPC1 (0.82) NPC1LMNAKMT2AMEN1CYP1A2
SCHEMBL3814590 0.86 NPC1 (0.82) NPC1LMNAKMT2AMEN1CYP1A2
SCHEMBL21679409 0.86 NPC1 (0.82) NPC1LMNAKMT2AMEN1CYP1A2
SCHEMBL29869422 0.86 NPC1 (0.82) NPC1LMNAKMT2AMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11142495-B2 Composition and method for manufacturing device using same TOYO GOSEI CO., LTD. (JP) 2021-10-12 US disclosed
US-20200048191-A1 COMPOSITION AND METHOD FOR MANUFACTURING DEVICE USING SAME TOYO GOSEI CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048191-A1 COMPOSITION AND METHOD FOR MANUFACTURING DEVICE USING SAME LBR, LMTK2, MMS19 NPC1 3614/4885LMNA 85/4885KMT2A 3015/4885
US-11142495-B2 Composition and method for manufacturing device using same LBR, LMTK2, MMS19 NPC1 3614/4885LMNA 85/4885KMT2A 3015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.